/PRNewswire/ Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition.
Precision Medicine Group Significantly Expands Cell And Gene Therapy Expertise With Acquisition Of Project Farma
News provided by
Share this article
Share this article
LEADING BIO-ENGINEERING AND MANUFACTURING SERVICES FIRM CATALYZES THE LAUNCH OF PRECISION S CELL AND GENE THERAPY OFFERING PRECISION ADVANCE ADDRESSING THE UNIQUE CHALLENGES OF CELL & GENE THERAPY INNOVATORS, FROM DEVELOPMENT THROUGH COMMERCIALIZATION
BETHESDA, Md., Jan. 14, 2021 /PRNewswire/ Precision Medicine Group ( PMG ) announced today it has acquired Project Farma, a patient-focused bioengineering services firm that supports life science innovators in the manufacturing and scale-up of advanced therapies. Project Farma provides Precision a market-leading expertise in the manufacturing of life-changing medicines, with a unique focus in the rapidly growing area of cell and gene therapy. The acquisition adds Project Farma s unique expertise to Precision s suite of end-to-end cell and gene therapy capabilit